News

Published on 30 Sep 2021 on Benzinga via Yahoo Finance

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody...

Article preview image

Here's a roundup of top developments in the biotech space over the last 24 hours:

Scaling The Peaks

Read the rest of the article
NASDAQ.GRAY price evolution
NASDAQ.REGN price evolution
NYSE.LLY price evolution
NASDAQ.PASG price evolution
ASX.GTG price evolution
NASDAQ.ADMA price evolution
NASDAQ.APLT price evolution
NASDAQ.RAPT price evolution
NASDAQ.CNTG price evolution
NASDAQ.INZY price evolution
NASDAQ.RPRX price evolution
NYSE.GSK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Bristol Myers (BMY) sBLA for Reblozyl Gets Priority Review

Bristol Myers Squibb BMY recently announced that the FDA has accepted for priority review the sup...

Zacks via Yahoo Finance 6 Dec 2021
10 Best Healthcare Stocks to Buy According to Greg Martinez’s Parkman Healthcare Partners

In this article, we discuss the 10 best healthcare stocks to buy according to Greg Martinez's Par...

Insider Monkey via Yahoo Finance 4 Dec 2021
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy...

Here's a roundup of top developments in the biotech space over the last 24 hours. Protagonist The...

Benzinga 3 Dec 2021
Merck Completes Acquisition of Acceleron Pharma

Merck (MRK) revealed that it has completed the acquisition of Acceleron Pharma Inc. (XLRN) throug...

SmarterAnalyst 23 Nov 2021
These 40 Mass. companies made the new Deloitte Fast 500 list - Boston Business Journal

Here are the 40 Bay State companies that made the latest installment of Deloitte's Technology Fas...

The Business Journals 17 Nov 2021
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial...

Here's a roundup of top developments in the biotech space over the last 24 hours: Merck & Co., In...

Benzinga 9 Nov 2021
Here’s Why You Should Consider Investing in Acceleron Pharma (XLRN)

Baron Funds, an asset management firm, published its “Baron Health Care Fund” third quarter 2021 ...

Insider Monkey via Yahoo Finance 8 Nov 2021
Boom Or Kaboom? M&A Is Hitting Records – But Some Activists ‘Just Say No’

Although the leaders of both companies extolled the benefits of combining Merck’s clinical and...

Forbes 8 Nov 2021
Boom Or Kaboom? M&A Is Hitting Records – But Some Activists ‘Just Say No’

Although the leaders of both companies extolled the benefits of combining Merck’s clinical and...

Forbes 7 Nov 2021
Why Earnings Season Could Be Great for Acceleron Pharma (XLRN)

Investors are always looking for stocks that are poised to beat at earnings season and Acceleron ...

Zacks via Yahoo Finance 5 Nov 2021

Copyright Statfolio @ 2024

Social Accounts